We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure [email protected]
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Depression in childhood and adolescence is a chronic, recurring, and highly morbid disorder associated with poor psychosocial functioning, suffering, and attempted and completed suicide. This chapter throws light on how to diagnose depression in children and adolescents. It explores how the clinical picture of depression changes between childhood and adulthood, and focuses on ways people can adapt interviewing techniques for children. The information that the parent conveys helps to structure the interview with the child and helps efficiently and completely to elicit symptoms from the child. Reliability on the Schedule for Affective Disorders and Schizophrenia for School-Aged Children (K-SADS) and other instruments suggests that the diagnosis of depression in children and adolescents could be made as reliably as these diagnoses are made in adults. Discussing psychopharmacologic treatment, the chapter highlights that for medication, a selective serotonin reuptake inhibitor (SSRI) is most likely the first choice.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.